SA
MEDP icon

Strategic Advocates’s Medpace MEDP Stock Holding History

Strategic Advocates’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.1K Sell
55
-16
-23% -$7.38K 0.11% 113
2026
Q1 		$34.1K Buy
+71
New +$36.4K 0.15% 99

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Strategic Advocates's MEDP Position: Q2 2026 in Review

Strategic Advocates reduced its Medpace (MEDP) stake by 23% in Q2 2026, selling an estimated $7.38K and leaving 55 shares worth $29.1K. The position accounts for 0.11% of the portfolio, ranked #113.

Strategic Advocates first reported a position in MEDP in Q1 2026 and has held it in 2 quarters since. The position peaked at $34.1K in Q1 2026. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Strategic Advocates held 55 shares of Medpace worth $29.1K as of Q2 2026.
  • Strategic Advocates sold 16 Medpace shares in Q2 2026, an estimated $7.38K.
  • Medpace made up 0.11% of Strategic Advocates's portfolio in Q2 2026, its #113 holding.
  • Strategic Advocates first reported a position in Medpace in Q1 2026 and has held it in 2 quarters since.
  • Strategic Advocates's Medpace position peaked at $34.1K in Q1 2026.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.